TAG ARCHIVES FOR PRIMR comments

11
Jul2017

Recently, PRIM&R submitted comments to the National Institutes of Health (NIH) in response to a Request for Information (RFI): Invitation to Comment on Inclusion in Clinical Research Across the Lifespan. Read more

25
Apr2016

Recently, PRIM&R submitted comments to the International Committee of Medical Journal Editors (ICMJE) in response to their proposed requirements for sharing clinical trial data. PRIM&R stated that we fully support initiatives to promote data sharing on the grounds it enhances the value of clinical research and the participation of human research subjects. Read more

4
Feb2016

PRIM&R submitted comments to the Department of Health and Human Services’ (DHHS) Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) in response to their jointly released draft guidance on meeting minutes for institutional review boards (IRBs) who oversee human subjects research under the FDA and/or DHHS regulations. Read more

17
Oct2012

by Amy Davis, JD, MPH, Senior Director for Programs and Publications

PRIM&R recently sent comments to Congressman Edward Markey, (D-MA), senior member of the House Energy and Commerce Committee, on a bill called the Trial and Experimental Studies Transparency (TEST) Act of 2012. The goal of the bill is to increase transparency of clinical trials by expanding reporting [...] Read more

Page 1 of 212